| Nichole Marie Toler, MOT, OTR/L | |
|
2645 N 3rd St, Harrisburg, PA 17110-2001 | |
| (717) 782-6880 | |
| Not Available |
| Full Name | Nichole Marie Toler |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2645 N 3rd St, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043311913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nichole Marie Toler, MOT, OTR/L 1860 Walnut Bottom Rd, Carlisle, PA 17015-7672 Ph: (770) 356-7345 | Nichole Marie Toler, MOT, OTR/L 2645 N 3rd St, Harrisburg, PA 17110-2001 Ph: (717) 782-6880 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of prostate cancer, but also can kill cancerous cells.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
› Verified 2 days ago
Joanna Rae Phillippy, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4300 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-920-4300 | |
Julie Lyn Cope, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1901 N. Fifth Street, Harrisburg, PA 17102 Phone: 717-221-7900 | |
Kristin Kaplewicz, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4310 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-657-7520 | |
Heather Mkeithan, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 409 S 2nd St, Suite 3f, Harrisburg, PA 17104 Phone: 717-230-3459 Fax: 717-230-3411 | |
Kristen Campbell, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 409 S 2nd St, Suite 3f, Harrisburg, PA 17104 Phone: 717-230-3459 Fax: 717-230-3411 | |
Angela Freeman Rutty, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5690 Allentown Blvd, Harrisburg, PA 17112 Phone: 717-216-8699 |